Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Benzathine Penicillin G in Healthy Japanese Subjects
NCT03612557Phase 1Completed
- Sponsor
- Pfizer
- Start
- Aug 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of benzathine penicillin G in syphilis, sponsored by Pfizer. Primary endpoints: Maximum observed plasma concentration for penicillin G at 648 hours, Time to Cmax at 648 hours and 5 more. Started Aug 2018; status: completed.
02
Drugs
benzathine penicillin G
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT03612557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03612557.